Clinical Trial

Digital App for Speech & Health Monitoring

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Many people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems. Using common digital technologies such as smartphone apps, the investigators can record and analyse speech in detail to provide new information for people living with these conditions, researchers, and healthcare professionals. This study will investigate the use of these digital speech recordings to help diagnose and monitor these conditions. To take part, participants will have either a diagnosis of dementia, motor neuron disease, Parkinson's disease or Multiple Sclerosis, OR they will have no diagnosis of a neurological condition. Researchers will compare people with a diagnosis of a Neurological condition to those without.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-03; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2024-09-16
Trial Details
NCT Number NCT06450418
Lead Sponsor University of Edinburgh
Collaborators: NHS Lothian
Conditions Dementia, Motor Neuron Disease, Multiple Sclerosis, Parkinson Disease
Enrollment 150 participants
Start Date 2024-07-12
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-18